search
for
 About Bioline  All Journals  Testimonials  Membership  News


Journal of Postgraduate Medicine
Medknow Publications and Staff Society of Seth GS Medical College and KEM Hospital, Mumbai, India
ISSN: 0022-3859 EISSN: 0972-2823
Vol. 49, Num. 1, 2003, pp. 81-82

Journal of Postgraduate Medicine, Vol. 49, No. 1, Jan-March, 2003, pp. 81-82

Images in Medicine

Harlequin Foetus

Bianca S, Ingegnosi C, Bonaffini F*

Dipartimento di Pediatria and *Dipartimento di Scienze Microbiologiche e Ginecologiche, Università di Catania, Italy
Address for Correspondence: Sebastiano Bianca, PhD, Dipartimento di Pediatria. Via S. Sofia, 78, 95123 - Catania, Italy E-mail: sebastiano.bianca@tiscali.it

Code Number: jp03017

We report a male with harlequin foetus (HF) a product of consanguineous union. The maternal age was 37 years and paternal age was 42 years. This baby born at 29 weeks of gestation was weighing 1300g at birth. He died 15 hours after birth.

Clinical examination showed the typical features of HF (Figures 1, 2) with the presence of plaques with a diamond-like configuration, ear anomalies, severe ectropion and eclabion. The limbs remained in rigid semi-flexion (Figure 3). The parents did not consent for autopsy and genetic examinations.

Discussion

Severe congenital ichthyoses, which are characterized by an intense hyperkeratosis on the whole body of the neonate, include several distinct types. Each type is related to different pathogenetic mechanisms.1 The classification is still a matter of debate, partly because the mechanisms of pathogenesis are not fully understood.

Harlequin foetus (MIM 242500), with an incidence of about 1 in 300,000 births, is a rare and extremely severe form of congenital ichthyosis. The condition is inherited as an autosomal recessive trait. It is characterized by plaques, measuring up to 4 or 5 cm on a side, that have a diamond-like configuration resembling the suit of a harlequin clown, severe ectropion and eclabion.2 The skin development is altered in utero; hyperkeratosis of the hair canal occurs in the second trimester and characteristic ultrastructural abnormalities are expressed in the affected fetal epidermis.2,3 Affected infants rarely survive beyond the first several weeks of life.

Skin morphological abnormalities reflect a defect of lipid content of lamellar granules: absent or abnormal lamellar granules in the granular cells, lipid droplets in stratum corneum and a lack of extra-cellular lipid lamellae have been reported in HF.4 Abnormalities in synthesis or metabolism of lipids in the lamellar granules are thought to be responsible for the morphological changes seen with HF and for the lack of desquamation and massive accumulation of scales.4 Defects of protein phosphatase activity in the epidermis are suggested to be a possible cause leading to the clinical features of HF because protein phosphatase is thought to function both in the processing of profilaggrin, a protein constituent of keratohyalin granules and in the regulation of lipid biosynthesis.2 It was also suggested that both epithelial and mesenchymal elements of the skin from HF are affected but that the primary abnormality lies in the keratinocytes.5

Evidence for recessive inheritance has been provided by several family reports and by parental consanguinity.6 Moreover, it has recently been suggested that a dominant mutation may possibly be responsible for the disorder and that parental mosaicism for mutations can lead to recurrence in subsequent pregnancies.2,7 Our case showed a double consanguinity that provides a strong evidence for a recessive inheritance.

Management of HF involves intensive care of the skin and eyes, close monitoring of fluid and electrolyte status, constant support to and counselling of parents, and surveillance against infections and side effects of medications. A well-coordinated multidisciplinary approach can prolong survival.

Knowledge of the pathogenetic mechanisms is significant for the precise diagnosis, treatment, genetic counselling and prenatal diagnosis.

References

  1. Akiyama M. Severe congenital ichthyosis of the neonate. Int J Dermatol 1998;37:722-8.
  2. Dale BA, Kam E. Harlequin ichthyosis: variability in expression and hypothesis for disease mechanism. Arch Dermatol 1993;129:1471-7.
  3. Akiyama M, Holbrook KA. Analysis of skin-derived amniotic fluid cells in the second trimester; detection of severe genodermatoses expressed in the fetal period. J Invest Dermatol 1994;103:674-7.
  4. Akiyama M. The pathogenesis of severe congenital ichthyosis of the neonate. J Dermatol Sci 1999;21:96-104.
  5. Flekman P, Hager B, Dale BA. Harlequin ichthyosis keratinocytes in lifted culture differentiate poorly by morphologic and biochemical criteria. J Invest Dermatol 1997;109:36-8.
  6. Unamuno P, Pierola JM, Fernandez E, Roman C, Velasco JA. Harlequin fetus in four siblings. Br J Dermatol 1987;116:569-72.
  7. Suzumori K, Kanzaki T. Pre-natal diagnosis of Harlequin ichthyosis by fetal skin biopsy: report of two cases. Prenat Diagn 1991;11:451-7.

Copyright 2003 - Journal of Postgraduate Medicine. Online full-text also available at http://www.jpgmonline.com/


The following images related to this document are available:

Photo images

[jp03017f2.jpg] [jp03017f1.jpg] [jp03017f3.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil